Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis

Respiratory Medicine

Volumn 106, Issue 3, 2012, Pages 356-360

  White, Laura ^a   Mirrani, Ghazi ^a   Grover, Mark ^a   Rollason, Judith ^a   Malin, Adam ^a   Suntharalingam, Jay ^a  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Bronchiectasis; Infective exacerbation; Pseudomonas

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ERADICATION THERAPY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KAPLAN-MEIER ESTIMATE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM; TREATMENT OUTCOME;

EID: 84855887761     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.11.018     Document Type: Article

References (18)

1. P.L. Ho, K.N. Chan, M.S. Ip, W.K. Lam, C.S. Ho, and K.Y. Yuen The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis Chest 114 1998 1594 1598 (Pubitemid 128487481)
2. C.B. Wilson, P.W. Jones, C.J. O'Leary, D.M. Hansell, P.J. Cole, and R. Wilson Effect of sputum bacteriology on the quality of life of patients with bronchiectasis Eur Respir J 10 1997 1754 1760 (Pubitemid 27368366)
3. M.A. Martinez-Garcia, J.J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis Chest 132 2007 1565 1572 (Pubitemid 350156014)
4. G. Davies, A.U. Wells, S. Doffman, S. Watanabe, and R. Wilson The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Eur Respir J 28 2006 974 979 (Pubitemid 46331967)
5. S.C. Langton Hewer, and A.R. Smyth Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis Cochrane Database Syst Rev 7 2009 CD004197
6. N.H. Valerius, C. Koch, and N. Høiby Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment Lancet 338 1991 725 726
7. M. Proesmans, L. Boulanger, F. Vermeulen, and K. De Boeck Eradication of recent Pseudomonas aeruginosa isolation: TOBI versus colistin/ciprofloxacin [abstract] J Cyst Fibros 7 2 2008 S64
8. R.L. Gibson, J. Emerson, S. McNamara, J.L. Burns, M. Rosenfeld, A. Yunker Cystic Fibrosis Therapeutics Development Network Study Group Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis Am J Crit Care Med 167 2003 841 849 (Pubitemid 36801771)
9. H.G. Wiesemann, G. Steinkamp, F. Ratjen, A. Baurnfeind, B. Przyklenk, and G. Döring Placebo-controlled, double-blind, randomised study of aerosolised tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis Pediatr Pulmonol 25 1998 88 92 (Pubitemid 28110583)
10. M.C. Pasteur, D. Bilton, and A.T. Hill British Thoracic Society guideline for non-CF bronchiectasis Thorax 65 2010 i1 58
11. Health Protection Agency Investigation of bronchoalveolar lavage, sputum and associated specimens National Standard Method BSOP 57 2.3 2009
12. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society Eur Respir J Suppl 16 1993 5 40
13. A.F. Barker, L. Couch, S.B. Fiel, M.H. Gotfried, J. Ilowite, and K.C. Meyer Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis Am J Respir Crit Care Med 162 2000 481 485 (Pubitemid 30647187)
14. R. Dhar, G.A. Anwar, S.C. Bourke, L. Doherty, P. Middleton, and C. Ward Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa Thorax 65 2010 553
15. M.E. Drobnic, P. Sune, J.B. Montoro, A. Ferrer, and R. Orriols Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa Ann Pharmacother 39 2005 39 44 (Pubitemid 40052376)
16. R. Orriols, J. Roig, J. Ferrer, G. Sampol, A. Rosell, and A. Ferrer Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa Respir Med 93 1999 476 480 (Pubitemid 29364062)
17. M.P. Murray, J.W. Govan, C.J. Doherty, J. Simpson, T.S. Wilkinson, and J.D. Chalmers A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis Am J Respir Crit Care Med 183 2011 491 499
18. P. Scheinberg, and E. Shore A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis Chest 127 2005 1420 1426 (Pubitemid 46224309)